ММВБ 4 031 1,5%  Nasdaq 14 897 1,0%  Биткойн 44 512 -0,9%  USD/RUB 73,0160 0,0% 
РТС 1 747 2,1%  S&P500 4 396 1,0%  Нефть 76,2 0,5%  EUR/RUB 85,2870 -0,1% 
Dow 34 258 1,0%  FTSE100 7 083 1,5%  Золото 1 762 -0,3%  EUR/USD 1,1692 -0,3% 

GlaxoSmithKline plc (GSK) - Профиль

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.


Название Доля (%)
Government Pension Fund - Global (The)2,49
Dodge & Cox International Stock Fund1,70
Caisse de Dépôt & Placement du Québec1,06
Capital Income Builder0,95


980 Great West Road, TW8 9GS Middlesex
Телефон: +44 (20) 8047-5000
Факс: +44 (20) 8047-7807
Вэб: http://gsk.com


María Cristina de Luna Basagoiti
Chairman & General Manager-Spain
Luke Miels
Chief Commercial Officer
Karenann K. Terrell
Chief Digital & Technology Officer
Emma N. Walmsley
Chief Executive Officer & Executive Director
Brian James McNamara
Chief Executive Officer-Consumer Healthcare
Iain James Mackay
Chief Financial Officer & Executive Director
David Simon Redfern
Chief Strategy Officer
Hal V. Barron
Executive Director & Chief Scientific Officer
Neil Barnes
Global Franchise Medical Head-Respiratory
Sarah-Jane Hall
Group Treasurer & Senior Vice President
Rab Prinjha
Head-Epigenetics Discovery Performance Unit
Sarah Elton-Farr
Head-Global Investor Relations
Anne C. Beal
Independent Non-Executive Director
Charles A. Bancroft
Independent Non-Executive Director
Jesse L. Goodman
Independent Non-Executive Director
Laurie H. Glimcher
Independent Non-Executive Director
Lynn Laverty Elsenhans
Independent Non-Executive Director
Urs Rohner
Independent Non-Executive Director
Vivienne Cox
Independent Non-Executive Director
Deborah Jayne Waterhouse
Member-Executive Board
Jonathan Richard Symonds
Non-Executive Chairman
Philip Thomson
President-Global Affairs
Regis Jean-Pierre Simard
President-Pharmaceutical Supply Chain
Maya Martinez-Davis
President-US Pharmaceuticals
Roger Connor
President-Vaccines & Global Health
Kevin Sin
SVP & Head-Worldwide Business Development
Amy Altshul
SVP-Legal, Research & Development
Tony Wood
SVP-Platform Technology & Science
Victoria A. Whyte
Manvinder Singh Banga
Senior Independent Non-Executive Director
James Ford
Senior Vice President & General Counsel
Christopher Corsico
Senior Vice President-Development
Diana Conrad
Senior Vice President-Human Resources
Marc Jones
Senior Vice President-Regional Pharma Supply
Jon Ellis
VP & Head-Technology Business Development
Seok Kian Tay
VP-Executive Compensation Strategy & Governance
Romulo Colindres
VP-Global Medical Affairs Lead for Zoster

Добавить или редактировать инструмент